Early and Proactive Treatment Makes a Difference

Acromegaly is a chronic rare disease associated with excess growth hormone secretion. It causes overgrowth of body tissues and, if untreated, can lead to secondary problems such as hypertension and heart failure. Failure to seek medical treatment for this condition can reduce life expectancy by 10 years.

On this page, you'll find information about the condition, its diagnosis and treatment, and links to useful Pfizer resources.

Disease Education Information

What Is Acromegaly?

Acromegaly is caused by a noncancerous tumor in the pituitary gland, the “master gland”of the body, which controls growth, metabolism, and reproductive activity and sits in the sella turcica at the base of the brain. This tumor, called a pituitary adenoma, causes the pituitary gland to secrete excess growth hormone, which results in the tissue overgrowth.

Patients with this condition experience an increase in the size of their hands and feet, broadening of their fingers, and coarsening and broadening of their facial features. They may also experience headaches and can often suffer from diabetes, hypertension, and heart failure.

Who Gets Acromegaly and How?

Only three or four patients per million individuals are diagnosed with the condition each year. Acromegaly develops gradually and typically is not diagnosed until several years—often, as many as seven—after excess growth hormone secretion has begun.

This condition usually occurs in patients without a family history of acromegaly. One should suspect the condition if the size of the patient’s shoes, rings, and gloves increase or if facial features start to coarsen and spaces between the upper front teeth widen.

What Are the Symptoms of Acromegaly

The main symptoms are caused by abnormally high growth hormone and insulin growth factor (IGF-I) levels, and some are caused by the tumor itself. They include the following:

  • Broadening of the nose, lips, ears, and forehead; enlarged tongue and increased spacing between front teeth
  • Headaches
  • Hoarse voice; sleep apnea and loud snoring
  • Growth in hands and feet that requires larger shoes, rings, and gloves
  • Appearance of skin tags and excessive sweating
  • Arthritis of large joints and joint pain
  • Polyps in the colon, thyroid, and uterus
  • Hypertension and heart failure
  • Diabetes. Diabetic patients with the condition may require higher doses of anti-diabetes medicines

When growth hormone levels are not controlled, and diabetes and heart disease are present, the patient’s life expectancy may be reduced by as much as 10 years.

How Is Acromegaly Diagnosed?

Because excess growth hormone levels stimulate increased production of IGF-1, acromegaly may be diagnosed either by measuring levels of insulin growth factor (IGF-I) or by measuring growth hormone levels directly. IGF-I measurement is the easiest detection method because it only requires a simple blood test and samples may be taken at any time of the day. Direct growth hormone measurement is more involved since it requires several recordings, both before and after the patient has ingested a glucose solution.

Once excessive growth hormone and IGF-I levels have been confirmed, magnetic resonance imaging (MRI) is used to examine the brain and determine whether a pituitary adenoma is present.

Can Acromegaly Be Treated?

In treating acromegaly, the goal is to restore growth hormone and IGF-I in the blood to normal levels. If treatment succeeds, the soft tissue overgrowth will improve over several months and the risk of decreased life expectancy will return to where it was before the condition was diagnosed.

Surgical removal of the tumor is usually the first choice, but medications will be needed if surgery does not cure the condition. Potential treatments include synthetic analogues of the hormone somatostatin, dopamine agonists, and growth hormone antagonists. In some cases, radiation therapy may be required.

Pfizer Rare Disease Resources for Acromegaly

For Healthcare Professionals
PfizerPro offers information on treatments for acromegaly and other rare diseases.
Pfizer Rare Disease Consortium
Pfizer is focusing on collaborations with world-class R&D organizations to advance and speed rare disease treatment innovations. The Pfizer Rare Disease Consortium in the UK, our first center of excellence in rare disease research, is a model for future collaborations in Europe and the US.
Grants and Contributions
Pfizer offers grants and funding for research and programs designed to improve daily life and outcomes for patients with rare diseases.
Rare Disease Research
A deeper understanding of the genetics of rare diseases gives us an opportunity to explore breakthrough science, new approaches, and pioneering collaborations to potentially deliver next-generation therapies for people living with rare diseases.